MedTrace Logo

Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion

NCT05821842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-04-26

Study results available
· View outcomes & findings →

Summary

To demonstrate the safety and effectiveness of Sonu for the treatment of patients suffering from moderate to severe nasal congestion.

Conditions

  • Nasal Congestion and Inflammations

Interventions

DEVICE

Sonu

Acoustic energy delivery

Sponsors & Collaborators

  • Third Wave Therapeutics

    lead INDUSTRY

Principal Investigators

  • Jacob Johnson, MD · San Francisco Otolaryngology Medical Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-23
Primary Completion
2023-04-30
Completion
2023-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05821842 on ClinicalTrials.gov